Hypophysitis Research Center

Literature

« Categorize your Article Search

176 Search Results matching "Case Series"
Sort Results by » Year Journal Author Entry ID
  1. A. Tauziede-Espariat, M. Polivka, S. Bouazza, P. Decq, G. Robert, M. Laloi-Michelin and H. Adle-Biassette, The prevalence of IgG4-positive plasma cells in hypophysitis: a possible relationship to IgG4-related disease. Clin Neuropathol, 2015. . View PDF
  2. Ahangari G, Ostadali MR, Rabani A, Rashidian J, Sanati MH, Zarindast MR, Growth hormone antibodies formation in patients treated with recombinant human growth hormone. International journal of immunopathology and pharmacology, 2004. 33-38. View PDF
  3. Ahmed, S.R., D.P. Aiello, R. Page, K. Hopper, J. Towfighi, and R.J. Santen, Necrotizing infundibulo-hypophysitis: a unique syndrome of diabetes insipidus and hypopituitarism. Journal of Clinical Endocrinology & Metabolism, 1993. 1499-504. View PDF
  4. Ansell SM, Hurvitz SA, Koenig PA, LaPlant BR, Kabat BF, Fernando D, Habermann TM, Inwards DJ, Verma M, Yamada R, Erlichman C, Lowy I, Timmerman JM., Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma. Clin Cancer Res, 2009. 6446-6453. View PDF
  5. Asa, S.L., J.M. Bilbao, K. Kovacs, R.G. Josse, and K. Kreines, Lymphocytic hypophysitis of pregnancy resulting in hypopituitarism: a distinct clinicopathologic entity. Annals of Internal Medicine, 1981. 166-71. View PDF
  6. Assi H, Wilson KS, Immune toxicities and long remission duration after ipilimumab therapy for metastatic melanoma: two illustrative cases. Current oncology (Toronto, Ont), 2013. e165-169. View PDF
  7. Atkins, D., R. Sanford, B. Thomas, and R. Joyner, Infundibuloneurohypophysitis in children. A report of 2 cases. Pediatr Neurosurg, 1999. 267-71. View PDF
  8. Attia P, Phan GQ, Maker AV, Robinson MR, Quezado MM, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Restifo NP, Haworth LR, Levy C, Mavroukakis SA, Nichol G, Yellin MJ, Rosenberg SA., Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.. J Clin Oncol, 2005. 6043-6053. View PDF
  9. B. S. Imber, H. S. Lee, S. Kunwar, L. S. Blevins and M. K. Aghi, Hypophysitis: a single-center case series. Pituitary, 2014. . View PDF
  10. B. T. Rodrigues, Z. Otty, K. Sangla and V. V. Shenoy, Ipilimumab-induced autoimmune hypophysitis: a differential for sellar mass lesions. Endocrinology, diabetes & metabolism case reports, 2014. 140098. View PDF
  11. Bachour E, Perrin G, Ciriano D, Trouillas J, Sassolas G, Tommasi M, Goutelle A, Idiopathic giant cell granulomas of the pituitary gland. Apropos of 2 cases. Neurochirurgie, 1991. 253-257. View PDF
  12. Bando H, Iguchi G, Fukuoka H, Masaaki T, Yamamoto M, Matsumoto R, Suda K, Nishizawa H, Takahashi M, Kohmura E, Takahashi Y, The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literature. Eur J Endocrinol, 2013. . View PDF
  13. Baskin, D.S., J.J. Townsend, and C.B. Wilson, Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma: a distinct pathological entity. Report of two cases. J Neurosurg, 1982. 148-53. View PDF
  14. Beck, K.E., J.A. Blansfield, K.Q. Tran, A.L. Feldman, M.S. Hughes, R.E. Royal, U.S. Kammula, S.L. Topalian, R.M. Sherry, D. Kleiner, M. Quezado, I. Lowy, M. Yellin, S.A. Rosenberg, and J.C. Yang, Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol, 2006. 2283-2289. View PDF
  15. Bensing, S., A.L. Hulting, A. Hoog, K. Ericson, and O. Kampe, Lymphocytic hypophysitis: report of two biopsy-proven cases and one suspected case with pituitary autoantibodies. J Endocrinol Invest, 2007. 153-162. View PDF
  16. Biering, H., G. Bohner, and C.J. Strasburger, Autoimmune hypophysitis--two case reports. Dtsch Med Wochenschr, 2005. 2826-2828. View PDF
  17. Blansfield, J.A., K.E. Beck, K. Tran, J.C. Yang, M.S. Hughes, U.S. Kammula, R.E. Royal, S.L. Topalian, L.R. Haworth, C. Levy, S.A. Rosenberg, and R.M. Sherry, Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. J Immunother, 2005. 593-598. View PDF
  18. Bleisch VR, Robbins SL, Sarcoid-like granulomata of the pituitary gland; a cause of pituitary insufficiency. AMA Arch Intern Med, 1952. 877-892. View PDF
  19. Boller R, Goedel A, Zur Kenntnis der Kilinik und pathologischen anatomie der multiplen blutdrusensclerose. Wiener Archives fur innere Medizine, 1935. 41-74. View PDF
  20. Bourdelle-Hego, M.F., D. Dewailly, J.P. Cappoen, C. Lingard-Leroy, and P. Fossati, Hypophysite du post partum, une ètiologie très souvent mécounnue d'hypopituitarism antérieur; à propos de 2 obsevations. Rev Franc Endocrinol Clin, 1985. 99-104. View PDF
  21. Bronstein Y, Ng CS, Hwu P, Hwu WJ., Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy. AJR Am J Roentgenol, 2011. W992-W1000. View PDF
  22. Burt, M. G. Morey, A. L. Turner, J. J. Pell, M. Sheehy, J. P. Ho, K. K., Xanthomatous pituitary lesions: a report of two cases and review of the literature. Pituitary, 2003. 161-168. View PDF
  23. Callahan MK, Wolchok JD, Allison JP, Anti-CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy. Seminars in oncology, 2010. 473-484. View PDF
  24. Cheung, C.C., S. Ezzat, H.S. Smyth, and S.L. Asa, The spectrum and significance of primary hypophysitis. J Clin Endocrinol Metab, 2001. 1048-53. View PDF
  25. Collin, P., M. Hakanen, J. Salmi, M. Maki, and K. Kaukinen, Autoimmune hypopituitarism in patients with coeliac disease: symptoms confusingly similar. Scand J Gastroenterol, 2001. 558-560. View PDF
  26. D. B. Johnson, D. L. Friedman, E. G. Berry, I. Decker, F. Ye, S. Zhao, A. K. Morgans, I. Puzanov, J. A. Sosman and C. M. Lovly, Survivorship in immune therapy: assessing chronic immune toxicities, health outcomes, and functional status among long-term ipilimumab survivors at a single referral center. Cancer immunology research, 2015. . View PDF
  27. D. Joshi, R. Jager, S. Hurel, S. P. Pereira, G. J. Johnson, M. Chapman, R. Fowler, A. Winstanley, N. Losseff and G. J. Webster, Cerebral involvement in IgG4-related disease. Clin Med, 2015. . View PDF
  28. D'Alva Rocha, C.B., and M.A.A. Pereira, Hipopituitarismo associado a hipoglicemia: relato de 2 casos e revisao da literatura. Arq Bras Endocrinol Metab, 2002. 593-600. View PDF
  29. De Sousa, S.M., G.V. Long, and K.T. Tonks, Ipilimumab-induced hypophysitis: early Australian experience. Med J Aust, 2014. 198-9. View PDF
  30. Di Iorgi, N., A.E. Maria Allegri, F. Napoli, A. Calcagno, E. Calandra, N. Fratangeli, M. Vannati, A. Rossi, F. Bagnasco, R. Haupt, and M. Maghnie, Central Diabetes Insipidus in Children and Young Adults: Etiological Diagnosis and Long - Term Outcome of Idiopathic Cases. J Clin Endocrinol Metab, 2013. . View PDF
  31. Doniach I, Wright EA, Two cases of giant-cell granuloma of the pituitary gland. J Pathol Bact, 1951. 69-79. View PDF
  32. Downey SG, Klapper JA, Smith FO, Yang JC, Sherry RM, Royal RE, Kammula US, Hughes MS, Allen TE, Levy CL, Yellin M, Nichol G, White DE, Steinberg SM, Rosenberg SA., Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade. Clin Cancer Res, 2007. 6681-6688. View PDF
  33. Duff, G.L. and C. Bernstein, Five cases of Addison's disease with so-called atrophy of the adrenal gland. Bull Johns Hopkins Hosp, 1933. 67-83. View PDF
  34. E. J. Wyluda, T. D. Cheng J Fau - Schell, J. S. Schell Td Fau - Haley, C. Haley Js Fau - Mallon, R. I. Mallon C Fau - Neves, G. Neves Ri Fau - Robertson, J. Robertson G Fau - Sivik, H. Sivik J Fau - Mackley, G. Mackley H Fau - Talamo, J. J. Talamo G Fau -, Durable complete responses off all treatment in patients with metastatic malignant melanoma after sequential immunotherapy followed by a finite course of BRAF inhibitor therapy. Cancer Biol Ther, 2015. . View PDF
  35. Eskes, S.A., E. Endert, E. Fliers, and W.M. Wiersinga, Prevalence of Growth Hormone Deficiency in Hashimoto's Thyroiditis. J Clin Endocrinol Metab, 2010. . View PDF
  36. Etzrodt, H., H. Eier, P. Knoringer, and G. Kratzsch, Immunohypophysitis, a case of hypopituitarism?. Acta Endocrinol, 1984. 137. View PDF
  37. F. Albarel, C. Gaudy, F. Castinetti, T. Carre, I. Morange, B. Conte-Devolx, J. J. Grob and T. Brue, Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma. Eur J Endocrinol, 2014. . View PDF
  38. F. X. Danlos, J. Pages C Fau - Roux, M. Roux J Fau - Jebali, J.-M. Jebali M Fau - Gornet, M. Gornet Jm Fau - Bagot, C. Bagot M Fau - Lebbe and C. Lebbe, Atypical severe immune-related adverse effects resulting from sequenced immunotherapy in melanoma. Melanoma Res, 2014. 178-179. View PDF
  39. Faje, A.T., R. Sullivan, D. Lawrence, N.A. Tritos, R. Fadden, A. Klibanski, and L. Nachtigall, Ipilimumab-induced Hypophysitis: A Detailed Longitudinal Analysis in a Large Cohort of Patients with Metastatic Melanoma. J Clin Endocrinol Metab, 2014. jc20142306. View PDF
  40. Famini P, Maya MM, Melmed S., Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab, 2011. 1633-1641. View PDF
  41. Flanagan, D.E., A.E. Ibrahim, D.W. Ellison, M. Armitage, M. Gawne-Cain, and P.D. Lees, Inflammatory hypophysitis - the spectrum of disease. Acta Neurochir (Wien), 2002. 47-56. View PDF
  42. Folkerth, R.D., Price, D.L., Jr., Schwartz, M., Black, P.M. & De Girolami, U., Xanthomatous hypophysitis. Am J Surg Pathol, 1998. 736-741. View PDF
  43. Fong L, Kwek SS, O'Brien S, Kavanagh B, McNeel DG, Weinberg V, Lin AM, Rosenberg J, Ryan CJ, Rini BI, Small EJ, Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF. Cancer research, 2009. 609-615. View PDF
  44. Freda, P.U., S.L. Wardlaw, and K.D. Post, Unusual causes of sellar/parasellar masses in a large transsphenoidal surgical series. J Clin Endocrinol Metab, 1996. 3455-9. View PDF
  45. G. J. Kaptain, D. A. Vincent, J. P. Sheehan and E. R. Laws, Jr., Transsphenoidal approaches for the extracapsular resection of midline suprasellar and anterior cranial base lesions. Neurosurgery, 2001. 94-100; discussion 100-101. View PDF
  46. Garcia-Centeno, R., J.P. Suarez-Llanos, E. Fernandez-Fernandez, V. Andia-Melero, P. Sanchez, and A. Jara-Albarran, Empty sella and primary autoimmune hypothyroidism. Clin Exp Med, 2009. . View PDF
  47. Gluck, M., A. Attanasio, U. Speer, O. Butenandt, H.U. Tietze, and W.A. Scherbaum, Prevalence of autoantibodies to endocrine organs in girls with Ullrich-Turner syndrome aged 5-14 years. Horm Res, 1992. 114-9. View PDF
  48. Gondim, J., M. Schops, and O.I. Tella, Jr., Transnasal endoscopic surgery of the sellar region: study of the first 100 cases. Arq Neuropsiquiatr, 2003. 836-841. View PDF
  49. Gossain, V.V. and D.R. Rovner, Primary hypothyroidism, pituitary insufficiency and pregnancy. A case report. J Reprod Med, 1984. 284-8. View PDF
  50. Goswami, R., N. Kochupillai, P.A. Crock, A. Jaleel, and N. Gupta, Pituitary autoimmunity in patients with Sheehan's syndrome. J Clin Endocrinol Metab, 2002. 4137-41. View PDF
  51. Gutenberg, A., R. Buslei, R. Fahlbusch, M. Buchfelder, and W. Bruck, Immunopathology of Primary Hypophysitis: Implications for Pathogenesis. Am J Surg Pathol, 2005. 329-338. View PDF
  52. Gutenberg, A., V. Hans, M.J. Puchner, J. Kreutzer, W. Bruck, P. Caturegli, and M. Buchfelder, Primary hypophysitis: clinical-pathological correlations. Eur J Endocrinol, 2006. 101-107. View PDF
  53. H. Bando, G. Iguchi, H. Fukuoka, M. Yamamoto, R. Hidaka-Takeno, Y. Okimura, R. Matsumoto, K. Suda, H. Nishizawa, M. Takahashi, K. Tojo and Y. Takahashi, Involvement of PIT-1-reactive cytotoxic T lymphocytes in anti-PIT-1 antibody syndrome. J Clin Endocrinol Metab, 2014. E1744-1749. View PDF
  54. Hashimoto, K., H. Kurokawa, T. Nishioka, T. Takao, K. Takeda, K. Takamatsu, and Y. Numata, Four patients with polyendocrinopathy with associated pituitary hormone deficiency. Endocr J, 1994. 613-21. View PDF
  55. Hashimoto, K.I., N. Yamakita, T. Ikeda, T. Matsuhisa, A. Kuwayama, T. Sano, K. Hashimoto, and K. Yasuda, Longitudinal Study of Patients with Idiopathic Isolated TSH Deficiency: Possible Progression of Pituitary Dysfunction in Lymphocytic Adenohypophysitis. Endocr J, 2006. 593-601. View PDF
  56. Hausler, M. Schaade, L. Ramaekers, V. T. Doenges, M. Heimann, G. Sellhaus, B., Inflammatory pseudotumors of the central nervous system: report of 3 cases and a literature review. Hum Pathol, 2003. 253-262. View PDF
  57. Hersh EM, O'Day SJ, Powderly J, Khan KD, Pavlick AC, Cranmer LD, Samlowski WE, Nichol GM, Yellin MJ, Weber JS, A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naive patients with advanced melanoma. Investigational new drugs, 2011. 489-498. View PDF
  58. Heshmati, H.M., M. Kujas, S. Casanova, P.C. Wollan, J. Racadot, R. Van Effenterre, P.J. Derome, and G. Turpin, Prevalence of lymphocytic infiltrate in 1400 pituitary adenomas. Endocr J, 1998. 357-61. View PDF
  59. Higuchi M, Arita N, Mori S, Satoh B, Mori H, Hayakawa T, Pituitary granuloma and chronic inflammation of hypophysis: clinical and immunohistochemical studies. Acta Neurochir (Wien), 1993. 152-158. View PDF
  60. Hindocha, A. M, Chaudhary BR, Kearney T, Pal P, Gnanalingham K, Lymphocytic hypophysitis in males. Journal of Clinical Neuroscience, 2013. . View PDF
  61. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbe C, Peschel C, Quirt I, Clark JI, Wol, Improved survival with ipilimumab in patients with metastatic melanoma.. N Engl J Med, 2010. 711-723. View PDF
  62. Honegger, J., R. Fahlbusch, A. Bornemann, J. Hensen, M. Buchfelder, M. Muller, and P. Nomikos, Lymphocytic and granulomatous hypophysitis: experience with nine cases. Neurosurgery, 1997. 713-722. View PDF
  63. Horvath, E., S. Vidal, L.V. Syro, K. Kovacs, H.S. Smyth, and H. Uribe, Severe lymphocytic adenohypophysitis with selective disappearance of prolactin cells: a histologic, ultrastructural and immunoelectron microscopic study. Acta Neuropathol (Berl), 2001. 631-7. View PDF
  64. Hoshimaru, M., N. Hashimoto, and H. Kikuchi, Central diabetes insipidus resulting from a nonneoplastic tiny mass lesion localized in the neurohypophyseal system. Surg Neurol, 1992. 1-6. View PDF
  65. Houdouin, L., M. Polivka, C. Henegar, A. Blanquet, O. Delalande, and J. Mikol, Pituitary germinoma and lymphocytic hypophysitis: a pitfall. Report of two cases. Ann Pathol, 2003. 349-54. View PDF
  66. Hrnciar, J., M. Hrnciarova, S. Kompis, and M. Dobakova, The polyglandular autoimmune endocrine syndrome. Does autoimmune hypophysitis exist?. Vnitr Lek, 1987. 39-47. View PDF
  67. Hunger-Battefeld, W., K. Fath, A. Mandecka, M. Kiehntopf, C. Kloos, U.A. Muller, and G. Wolf, Prevalence of polyglandular autoimmune syndrome in patients with diabetes mellitus type 1. Med Klin (Munich), 2009. 183-191. View PDF
  68. Illig R, Growth hormone antibodies in patients treated with different preparations of human growth hormone (HGH). J Clin Endocrinol Metab, 1970. 679-688. View PDF
  69. Imura, H., K. Nakao, A. Shimatsu, Y. Ogawa, T. Sando, I. Fujisawa, and H. Yamabe, Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus. N Engl J Med, 1993. 683-9. View PDF
  70. Ishihara, T., M. Hino, H. Kurahachi, H. Kobayashi, M. Kajikawa, K. Moridera, K. Ikekubo, and N. Hattori, Long-term clinical course of two cases of lymphocytic adenohypophysitis. Endocr J, 1996. 433-40. View PDF
  71. J. Honegger, M. Buchfelder, S. Schlaffer, M. Droste, S. Werner, C. Strasburger, S. Stormann, J. Schopohl, S. Kacheva, T. Deutschbein, G. Stalla, J. Flitsch, M. Milian, S. Petersenn and U. Elbelt, Treatment of Primary Hypophysitis in Germany. J Clin Endocrinol Metab, 2015. jc20152146. View PDF
  72. J. J. Luke, M. A. Callahan Mk Fau - Postow, E. Postow Ma Fau - Romano, N. Romano E Fau - Ramaiya, M. Ramaiya N Fau - Bluth, A. Bluth M Fau - Giobbie-Hurder, D. P. Giobbie-Hurder A Fau - Lawrence, N. Lawrence Dp Fau - Ibrahim, P. A. Ibrahim N Fau - Ott, K., Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience. Cancer, 2013. . View PDF
  73. Jenkins, P.J., S.L. Chew, D.G. Lowe, F. Afshart, M. Charlesworth, G.M. Besser, and J.A. Wass, Lymphocytic hypophysitis: unusual features of a rare disorder. Clinical Endocrinology, 1995. 529-34. View PDF
  74. Jinguji S, Nishiyama K, Yoshimura J, Yoneoka Y, Harada A, Sano M, Fujii Y, Endoscopic biopsies of lesions associated with a thickened pituitary stalk. Acta Neurochir (Wien), 2013. 119-124; discussion 124. View PDF
  75. K. Kovacs and E. Horvath, The differential diagnosis of lesions involving the sella turcica. Endocr Pathol, 2001. 389-395. View PDF
  76. Kakizawa, Y., Y. Tanaka, K. Kitazawa, T. Tada, K. Hongo, and S. Kobayashi, Three cases of lymphocytic infundibuloneurohypophysitis. Horumon To Rinsho, 1999. 162-166. View PDF
  77. Kasperlik-Zaluska, A.A., B. Czarnocka, and W. Czech, Autoimmunity as the most frequent cause of idiopathic secondary adrenal insufficiency: report of 111 cases. Autoimmunity, 2003. 155-159. View PDF
  78. Kasperlik-Zaluska, A.A., B. Czarnocka, W. Czech, J. Walecki, A.M. Makowska, J. Brzezinski, and J. Aniszewski, Secondary adrenal insufficiency associated with autoimmune disorders: a report of twenty-five cases. Clin Endocrinol (Oxf), 1998. 779-783. View PDF
  79. Khare, S., V.S. Jagtap, S.R. Budyal, R. Kasaliwal, H.R. Kakade, A. Bukan, S. Sankhe, A.R. Lila, T. Bandgar, P.S. Menon, and N.S. Shah, Primary (autoimmune) hypophysitis: a single centre experience. Pituitary, 2013. . View PDF
  80. Kiaer, W. and J.O. Norgaard, Granulomatous hypophysitis and thyroiditis with lymphocytic adrenalitis. Acta Pathologica et Microbiologica Scandinavica, 1969. 229-38. View PDF
  81. Kim, Y.I., J.S. Jeon, Y.J. Kim, S.W. Park, Y.H. Byun, J.Y. Lee, and H.I. Kang, A case of lymphocytic hypophysitis associated with Rathke's cleft cyst. Korean Journal of Medicine, 2005. 565-570. View PDF
  82. Kirkwood JM, Lorigan P, Hersey P, Hauschild A, Robert C, McDermott D, Marshall MA, Gomez-Navarro J, Liang JQ, Bulanhagui CA, Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma. Clin Cancer Res, 2010. 1042-1048. View PDF
  83. Koutourousiou M, Kontogeorgos G, Seretis A, Non-adenomatous sellar lesions: experience of a single centre and review of the literature. Neurosurg Rev, 2010. 465-476. View PDF
  84. Krimholtz, M.J., S. Thomas, J. Bingham, and J.K. Powrie, Lymphocytic hypophysitis: spontaneous resolution on MRI with progression of endocrine defect. Int J Clin Pract, 2001. 339-40. View PDF
  85. Ku GY, Yuan J, Page DB, Schroeder SE, Panageas KS, Carvajal RD, Chapman PB, Schwartz GK, Allison JP, Wolchok JD., Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival.. Cancer, 2010. 1767-1775. View PDF
  86. Kurino, M., H. Seto, M. Miura, J. Kuratu, and Y. Ushio, Three cases of lymphocytic adenohypophysitis. Hormone to Rinsho, 1993. 182-185. View PDF
  87. L. Min, F. S. Hodi, A. Giobbie-Hurder, P. A. Ott, J. J. Luke, H. Donahue, M. Davis, R. S. Carroll and U. B. Kaiser, Systemic high dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study. Clin Cancer Res, 2014. . View PDF
  88. La Mantia, L. and A. Erbetta, Headache and inflammatory disorders of the central nervous system. Neurol Sci, 2004. S148-53. View PDF
  89. Lammert A, Schneider HJ, Bergmann T, Benck U, Kramer BK, Gartner R, Metzner C, Schofl C, Berking C, Hypophysitis Caused by Ipilimumab in Cancer Patients: Hormone Replacement or Immunosuppressive Therapy. Exp Clin Endocrinol Diabetes, 2013. . View PDF
  90. Lee, J.H., E.R. Laws, Jr., B.L. Guthrie, T.S. Dina, and L.E. Nochomovitz, Lymphocytic hypophysitis: occurrence in two men. Neurosurgery, 1994. 159-62; discussion 162-3. View PDF
  91. Leung, G.K., M.B. Lopes, M.O. Thorner, M.L. Vance, and E.R. Laws, Jr., Primary hypophysitis: a single-center experience in 16 cases. J Neurosurg, 2004. 262-71. View PDF
  92. Lindstrom, K.M., Cousar, J.B. & Lopes, M.B., IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria. Acta Neuropathol, 2010. . View PDF
  93. Lu, Z.H., J.M. Lu, W.S. Jin, J.T. Dou, Y.M. Mu, and C.Y. Pan, Lymphocytic hypophysitis: a report of 3 cases. Zhonghua Nei Ke Za Zhi, 2005. 446-449. View PDF
  94. Lupi I, Manetti L, Caturegli P, Menicagli M, Cosottini M, Iannelli A, Acerbi G, Bevilacqua G, Bogazzi F, Martino E, Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor clinical outcome after surgery in patients with pituitary adenoma. J Clin Endocrinol Metab, 2010. 289-296. View PDF
  95. Lynch TJ, Bondarenko I, Luft A, Serwatowski P, Barlesi F, Chacko R, Sebastian M, Neal J, Lu H, Cuillerot JM, Reck M, Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study. J Clin Oncol, 2012. 2046-2054. View PDF
  96. M. Alexander, J. D. Mellor, G. McArthur and D. Kee, Ipilimumab in pretreated patients with unresectable or metastatic cutaneous, uveal and mucosal melanoma. The Medical journal of Australia, 2014. 49-53. View PDF
  97. M. Mahzari, D. Liu, A. Arnaout and H. Lochnan, Immune Checkpoint Inhibitor Therapy Associated Hypophysitis. Clin Med Insights Endocrinol Diabetes, 2015. . View PDF
  98. Maker AV, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Hughes M, Yellin MJ, Haworth LR, Levy C, Allen T, Mavroukakis SA, Attia P, Rosenberg SA., Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma. J Immunother, 2006. 455-463. View PDF
  99. Marlier, J., V. Cocquyt, L. Brochez, S. Van Belle, and V. Kruse, Ipilimumab, not just another anti-cancer therapy: hypophysitis as side effect illustrated by four case-reports. Endocrine, 2014. . View PDF
  100. Massa G, Vanderschueren-Lodeweyckx M, Bouillon R, Five-year follow-up of growth hormone antibodies in growth hormone deficient children treated with recombinant human growth hormone. Clin Endocrinol (Oxf), 1993. 137-142. View PDF
  101. McDermott, M.W., D.E. Griesdale, K. Berry, and E. Wilkins, Lymphocytic adenohypophysitis. Can J Neurol Sci, 1988. 38-43. View PDF
  102. Melgar, M.A., N. Mariwalla, D.S. Gloss, and J.W. Walsh, Recurrent lymphocytic hypophysitis and bilateral intracavernous carotid artery occlusion. an observation and review of the literature. Neurol Res, 2006. 177-183. View PDF
  103. Meloni A, Willcox N, Meager A, Atzeni M, Wolff AS, Husebye ES, Furcas M, Rosatelli MC, Cao A, Congia M., Autoimmune Polyendocrine Syndrome Type 1: An Extensive Longitudinal Study in Sardinian Patients.. J Clin Endocrinol Metab, 2012. . View PDF
  104. Menon, S.K., V. Sarathi, T.R. Bandgar, P.S. Menon, N. Goel, and N.S. Shah, Autoimmune hypophysitis: a single centre experience. Singapore Med J, 2009. 1080-1084. View PDF
  105. Min L, Vaidya A, Becker C., Ipilimumab therapy for advanced melanoma is associated with secondary adrenal insufficiency: a case series.. Endocr Pract, 2011. 1/13/2012. View PDF
  106. Mirocha, S., R.B. Elagin, S. Salamat, and J.C. Jaume, T regulatory cells distinguish two types of primary hypophysitis. Clin Exp Immunol, 2009. 403-411. View PDF
  107. Miura, M., Y. Ushio, J. Kuratsu, J. Ikeda, Y. Kai, and S. Yamashiro, Lymphocytic adenohypophysitis: report of two cases. Surg Neurol, 1989. 463-70. View PDF
  108. Ng, W.H., M. Gonzales, and A.H. Kaye, Lymphocytic hypophysitis. J Clin Neurosci, 2003. 409-13. View PDF
  109. Nishioka, H., H. Ito, A. Hirano, N. Shibata, and M. Kobayashi, Immunocytochemical demonstration of the expression and induction of manganese-superoxide dismutase in the adenohypophysis. Histochem J, 1998. 231-236. View PDF
  110. Nishioka, H., H. Ito, T. Sano, and Y. Ito, Two cases of lymphocytic hypophysitis presenting with diabetes insipidus: a variant of lymphocytic infundibulo-neurohypophysitis. Surgical Neurology, 1996. 285-90; discussion 290-1. View PDF
  111. Nishioka, H., Shibuya, M. & Haraoka, J., Immunohistochemical Study for IgG4-positive Plasmacytes in Pituitary Inflammatory Lesions. Endocr Pathol, 2010. . View PDF
  112. Nussbaum, C.E., S.H. Okawara, and L.S. Jacobs, Lymphocytic hypophysitis with involvement of the cavernous sinus and hypothalamus. Neurosurgery, 1991. 440-4. View PDF
  113. Oda, Y., Y. Kamijyo, and Y. Kang, Lymphocytic hypophysitis: two cases with sellar tumors spontaneously disappearing on CT. No Shinkei Geka, 1986. 1155-59. View PDF
  114. O'Day SJ, Maio M, Chiarion-Sileni V, Gajewski TF, Pehamberger H, Bondarenko IN, Queirolo P, Lundgren L, Mikhailov S, Roman L, Verschraegen C, Humphrey R, Ibrahim R, de Pril V, Hoos A, Wolchok JD, Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 2010. 1712-1717. View PDF
  115. Oeckler RCT, Bise K, Non-specific granulomas of the pituitary: report of six cases treated surgically. Neurosurg Rev, 1991. 185-190. View PDF
  116. Parent, A.D., J.M. Cruse, and E.E. Smith, Lymphocytic hypophysitis: autoimmune reaction?. Adv Biosci, 1988. 465-469. View PDF
  117. Park, S.M., J.C. Bae, J.Y. Joung, Y.Y. Cho, T.H. Kim, S.M. Jin, S. Suh, K.Y. Hur, and K.W. Kim, Clinical Characteristics, Management, and Outcome of 22 Cases of Primary Hypophysitis. Endocrinol Metab (Seoul), 2014. . View PDF
  118. Patel, M.C., N. Guneratne, N. Haq, T.E. West, A.P. Weetman, and R.N. Clayton, Peripartum hypopituitarism and lymphocytic hypophysitis. Qjm, 1995. 571-80. View PDF
  119. Phan, G.Q., J.C. Yang, R.M. Sherry, P. Hwu, S.L. Topalian, D.J. Schwartzentruber, N.P. Restifo, L.R. Haworth, C.A. Seipp, L.J. Freezer, K.E. Morton, S.A. Mavroukakis, P.H. Duray, S.M. Steinberg, J.P. Allison, T.A. Davis, and S.A. Rosenberg, Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci U S A, 2003. 8372-8377. View PDF
  120. Philpot, M., J. Colgan, R. Levy, A. Holland, R. Mirakian, C.A. Richardson, and G.F. Bottazzo, Prolactin cell autoantibodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry, 1985. 287-288. View PDF
  121. Postow MA, Luke JJ, Bluth MJ, Ramaiya N, Panageas KS, Lawrence DP, Ibrahim N, Flaherty KT, Sullivan RJ, Ott PA, Callahan MK, Harding JJ, D'Angelo SP, Dickson MA, Schwartz GK, Chapman PB, Gnjatic S, Wolchok JD, Hodi FS, Carvajal RD, Ipilimumab for patients with advanced mucosal melanoma. The oncologist, 2013. 726-732. View PDF
  122. Pouplard, A., J. Emile, and F. Vincent-Pineau, Circulating human pituitary prolactin cell autoantibodies and Alzheimer's disease. Rev Neurol (Paris), 1983. 187-191. View PDF
  123. Powe CE, Allen M, Puopolo KM, Merewood A, Worden S, Johnson LC, Fleischman A, Welt CK, Recombinant human prolactin for the treatment of lactation insufficiency. Clin Endocrinol (Oxf), 2010. 645-653. View PDF
  124. Puchner, M.J., D.K. Ludecke, and W. Saeger, The anterior pituitary lobe in patients with cystic craniopharyngiomas: three cases of associated lymphocytic hypophysitis. Acta Neurochirurgica, 1994. 38-43. View PDF
  125. Puschel W, Wernert N, Hinkeldey K, Klein M, Brittner-Flemmer V, Remberger K, Granulomatous hypophysitis. Report of three cases and review of the literature. Pathologe, 1992. 100-103. View PDF
  126. Quentien MH, Delemer B, Papadimitriou DT, Souchon PF, Jaussaud R, Pagnier A, Munzer M, Jullien N, Reynaud R, Galon-Faure N, Enjalbert A, Barlier A, Brue T., Deficit in anterior pituitary function and variable immune deficiency (DAVID) in children presenting with adrenocorticotropin deficiency and severe infections.. J Clin Endocrinol Metab, 2012. E121-128. View PDF
  127. R. Cheng, A. Cooper, J. Kench, G. Watson, W. Bye, C. McNeil and N. Shackel, Ipilimumab-induced toxicities and the gastroenterologist. Journal of gastroenterology and hepatology, 2015. . View PDF
  128. R. Villani, C. Papagno, G. Tomei, N. Grimoldi, D. Spagnoli and L. Bello, Transcallosal approach to tumors of the third ventricle. Surgical results and neuropsychological evaluation. J Neurosurg Sci, 1997. 41-50. View PDF
  129. Ribas, A., B. Comin-Anduix, B. Chmielowski, J. Jalil, P. de la Rocha, T.A. McCannel, M.T. Ochoa, E. Seja, A. Villanueva, D.K. Oseguera, B.R. Straatsma, A.J. Cochran, J.A. Glaspy, L. Hui, F.M. Marincola, E. Wang, J.S. Economou, and J. Gomez-Navarro, Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma. Clin Cancer Res, 2009. 6267-6276. View PDF
  130. Ricciuti, A., A. De Remigis, M.A. Landek-Salgado, L. De Vincentiis, F. Guaraldi, I. Lupi, S. Iwama, G.S. Wand, R. Salvatori, and P. Caturegli, Detection of pituitary antibodies by immunofluorescence. Approach and results in patients with pituitary diseases. J Clin Endocrinol Metab, 2014. jc20141049. View PDF
  131. Rickards AG, Harvey PW, Giant-cell granuloma and the other pituitary granuolomata. Q J Med, 1954. 425-439. View PDF
  132. Robison, N.J., S.P. Prabhu, P. Sun, S.N. Chi, M.W. Kieran, P.E. Manley, L.E. Cohen, L. Goumnerova, E.R. Smith, R.M. Scott, W.B. London, and N.J. Ullrich, Predictors of neoplastic disease in children with isolated pituitary stalk thickening. Pediatr Blood Cancer, 2013. 1630-5. View PDF
  133. Royal RE, Levy C, Turner K, Mathur A, Hughes M, Kammula US, Sherry RM, Topalian SL, Yang JC, Lowy I, Rosenberg SA., Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma. J Immunother, 2010. 828-833. View PDF
  134. Ryder, M., M. Callahan, M.A. Postow, J. Wolchok, and J.A. Fagin, Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution. Endocr Relat Cancer, 2014. 371-81. View PDF
  135. S. Hama, K. Arita, T. Nishisaka, T. Fukuhara, A. Tominaga, K. Sugiyama, H. Yoshioka, K. Eguchi, M. Sumida, Y. Heike and K. Kurisu, Changes in the epithelium of Rathke cleft cyst associated with inflammation. J Neurosurg, 2002. 209-216. View PDF
  136. Saeger, W., R. Moser, and N. Wernert, Inflammatory infiltrates in the hypophysis. Studies of a large autopsy sample. Pathologe, 1987. 261-267. View PDF
  137. Sarnaik AA, Yu B, Yu D, Morelli D, Hall M, Bogle D, Yan L, Targan S, Solomon J, Nichol G, Yellin M, Weber JS., Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanoma.. Clin Cancer Res, 2011. 896-906. View PDF
  138. Scheithauer, B.W., T. Sano, K.T. Kovacs, W.F. Young, Jr., N. Ryan, and R.V. Randall, The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc, 1990. 461-74. View PDF
  139. Selch, M.T., A.A. DeSalles, D.F. Kelly, L. Frighetto, H.V. Vinters, C. Cabatan-Awang, R.E. Wallace, and T.D. Solberg, Stereotactic radiotherapy for the treatment of lymphocytic hypophysitis. Report of two cases. J Neurosurg, 2003. 591-6. View PDF
  140. Shanklin, W.M., Lymphocytes and lymphoid tissue in the human pituitary. Anat Rec, 1951. 177-185. View PDF
  141. Sheehan HL, Summers VK, The syndrome of hypopituitarism. Q J Med, 1949. 319-378. View PDF
  142. Sheen, K.C., C.C. Chang, T.C. Chang, and H.M. Liu, Thickened pituitary stalk with central diabetes insipidus: report of three cases. J Formos Med Assoc, 2001. 198-204. View PDF
  143. Shi J, Zhang JM, Wu Q, Chen G, Zhang H, Bo WL, Granulomatous hypophysitis: two case reports and literature review. J Zhejiang Univ Sci B, 2009. 552-558. View PDF
  144. Shimatsu A, Shimatsu S, Nanba K, Oki Y, IgG4-related infundibulo-hypophysitis. Annual Review diabetes metabolism, 2012. 199-206. View PDF
  145. Simmonds M, Uber das Vorkommen von Riesenzelle in der Hypophyse. Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin, 1916. 281-290. View PDF
  146. Simmonds, J.P. and W.W. Brandes, The pathology of the hypophysis. II. Lymphocytic infiltration. Am J Pathol, 1925. 273-280. View PDF
  147. Smith, C. J. Oscarson, M. Ronnblom, L. Alimohammadi, M. Perheentupa, J. Husebye, E. S. Gustafsson, J. Nordmark, G. Meloni, A. Crock, P. A, Kampe, O. Bensing, S., TSGA10 - A target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemic lupus erythematosus. Scand J Immunol, 2011. 147-153. View PDF
  148. Sosa, G.A., S. Bell, S.B. Christiansen, M. Pietrani, M. Glerean, M. Loto, S. Lovazzano, A. Carrizo, P. Ajler, and P. Fainstein Day, Histologically confirmed isolated IgG4-related hypophysitis: two case reports in young women. Endocrinol Diabetes Metab Case Rep, 2014. 140062. View PDF
  149. Su, C., Hypophysitis mimicking a pituitary adenoma (report of 3 cases). Chung-Kuo i Hsueh Ko Hsueh Yuan Hsueh Pao Acta Academiae Medicinae Sinicae, 1991. 376-9. View PDF
  150. Su, S.B., Zhang, D.J., Yue, S.Y. & Zhang, J.N., Primary granulomatous hypophysitis: a case report and literature review. Endocr J, 2011. . View PDF
  151. T. Lam, M. M. Chan, A. N. Sweeting, S. M. De Sousa, A. Clements, M. S. Carlino, G. V. Long, K. Tonks, E. Chua, R. F. Kefford and D. R. Chipps, Ipilimumab-induced hypophysitis in melanoma patients: An Australian case series. Intern Med J, 2015. . View PDF
  152. Tashiro, T., T. Sano, B. Xu, S. Wakatsuki, N. Kagawa, H. Nishioka, S. Yamada, and K. Kovacs, Spectrum of different types of hypophysitis: a clinicopathologic study of hypophysitis in 31 cases. Endocr Pathol, 2002. 183-95. View PDF
  153. Teufel, A. Weinmann, A. Kahaly, G. J. Centner, C. Piendl, A. Wörns, M. Lohse, A. W. Galle, P. R. Kanzler, S., Concurrent autoimmune diseases in patients with autoimmune hepatitis. Journal of Clinical Gastroenterology, 2010. 208-213. View PDF
  154. Thodou, E., S.L. Asa, G. Kontogeorgos, K. Kovacs, E. Horvath, and S. Ezzat, Lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab, 1995. 2302-11. View PDF
  155. Trabelsi, L., M. Mnif, N. Rekik, N. Kaffel, N. Charfi, J. Mnif, M.S. Kchaow, and M. Abid, MRI pituitary stalk abnormalities: etiology aspects in 11 patients. Ann Endocrinol (Paris), 2006. 604-612. View PDF
  156. Tran, H.A., G.E. Reeves, T.J. Lyons, and J.R. Attia, Histopathological Findings of Autoimmunity in Thyroid, Pituitary and Adrenal Diseases in Chronic Hepatitis C Post-Mortem Cases. Endocr Pract, 2010. 1/12/2010. View PDF
  157. Tsametis, C., N. Karavitaki, H.E. Turner, and J.A. Wass, Lymphocytic hypophysitis: what is the long-term outcome?. Endocrine Abstracts, 2005. P122. View PDF
  158. Turner, H.E., C.B. Adams, and J.A. Wass, Pituitary tumours in the elderly: a 20 year experience. Eur J Endocrinol, 1999. 383-389. View PDF
  159. Unluhizarci, K., F. Bayram, R. Colak, F. Ozturk, A. Selcuklu, A.C. Durak, and F. Kelestimur, Distinct radiological and clinical appearance of lymphocytic hypophysitis. J Clin Endocrinol Metab, 2001. 1861-1864. View PDF
  160. V. Wilson, J. W. Mallipedhi A Fau - Stephens, R. M. Stephens Jw Fau - Redfern, D. E. Redfern Rm Fau - Price and D. E. Price, The causes of hypopituitarism in the absence of abnormal pituitary imaging. QMJ, 2014. 21-24. View PDF
  161. van den Eertwegh AJ, Versluis J, van den Berg HP, Santegoets SJ, van Moorselaar RJ, van der Sluis TM, Gall HE, Harding TC, Jooss K, Lowy I, Pinedo HM, Scheper RJ, Stam AG, von Blomberg BM, de Gruijl TD, Hege K, Sacks N, Gerritsen WR., Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial.. The lancet oncology, 2012. . View PDF
  162. van Dorp, T.A., L.J. Endtz, J. te Velde, J.P. Slaets, and J. Reichgelt, Prolactin cell autoantibodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry, 1985. 1308-1309. View PDF
  163. Vernant JC, Cabre P, Smadja D, Merle H, Caubarrere I, Mikol J, Poser CM, Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology, 1997. 58-64. View PDF
  164. Viale GL, Giant cell tumours of the sellar region. Acta Neurochir (Wien), 1977. 259-268. View PDF
  165. Virally-Monod, M.L., Z. Barrou, C. Basin, P. Thomopoulos, and J.P. Luton, Lymphocytic hypophysitis: a reality. Presse Medicale, 1996. 933-8. View PDF
  166. Voskens CJ, Goldinger SM, Loquai C, Robert C, Kaehler KC, Berking C, Bergmann T, Bockmeyer CL, Eigentler T, Fluck M, Garbe C, Gutzmer R, Grabbe S, Hauschild A, Hein R, Hundorfean G, Justich A, Keller U, Klein C, Mateus C, Mohr P, Paetzold S, Satzger I, Sc, The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network. PloS one, 2013. e53745. View PDF
  167. W. Lin, S. Lu, H. Chen, Q. Wu, Y. Fei, M. Li, X. Zhang, X. Tian, W. Zheng, X. Leng, D. Xu, Q. Wang, M. Shen, L. Wang, J. Li, D. Wu, L. Zhao, C. Wu, Y. Yang, L. Peng, J. Zhou, Y. Wang, Y. Sha, X. Huang, Y. Jiao, X. Zeng, Q. Shi, P. Li, S. Zhang, C. Hu, C. , Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology (Oxford), 2015. . View PDF
  168. Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR, Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf), 1992. 45-52. View PDF
  169. Wiedemayer, H., I.E. Sandalcioglu, and D. Stolke, The supraorbital keyhole approach via an eyebrow incision for resection of tumors around the sella and the anterior skull base. Minim Invasive Neurosurg, 2004. 221-5. View PDF
  170. Y. Hayashi, M. Oishi, D. Kita, T. Watanabe, O. Tachibana and J. I. Hamada, Pure lymphocytic infundibuloneurohypophysitis caused by the rupture of Rathke's cleft cyst: Report of 2 cases and review of the literature. Turkish neurosurgery, 2015. 332-336. View PDF
  171. Y. Wada, Y. Hamamoto, Y. Nakamura, S. Honjo, Y. Kawasaki, H. Ikeda, J. Takahashi, Y. Yuba, A. Shimatsu and H. Koshiyama, Lymphocytic panhypophysitis: its clinical features in Japanese cases. Japanese clinical medicine, 2011. 15-20. View PDF
  172. Yamamoto, M. Iguchi, G. Takeno, R. Okimura, Y. Sano, T. Takahashi, M. Nishizawa, H. Handayaningshi, A. E. Fukuoka, H. Tobita, M. Saitoh, T. Tojo, K. Mokubo, A. Morinobu, A. Iida, K. Kaji, H. Seino, S. Chihara, K. Takahashi, Y., Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans. J Clin Invest, 2011. 113-119. View PDF
  173. Yan, X., and D. Jiao, Non-pituitary adenomatous lesions in the sella turcica. Chinese Journal of Clinical Oncology, 2000. 119-121. View PDF
  174. Yang, G.Q., Lu, Z.H., Gu, W.J., Du, J., Guo, Q.H., Wang, X.L., Ba, J.M., Dou, J.T., Mu, Y.M. & Lu, J.M., Recurrent autoimmune hypophysitis successfully treated with glucocorticoids plus azathioprine: a report of three cases. Endocr J, 2011. . View PDF
  175. Yang, J.C., M. Hughes, U. Kammula, R. Royal, R.M. Sherry, S.L. Topalian, K.B. Suri, C. Levy, T. Allen, S. Mavroukakis, I. Lowy, D.E. White, and S.A. Rosenberg, Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis. J Immunother, 2007. 825-830. View PDF
  176. Zanchi, M. and E. Dova, Sugli accumuli di cellule linfoidi nell'ipofisi umana. Folia Endocrinologica (Pisa), 1950. 3-13. View PDF